SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Universal third-trimester ultrasonic screening using fetal macrosomia in the prediction of adverse perinatal outcome: A systematic review and meta-analysis of diagnostic test accuracy.

Moraitis, AA; Shreeve, N; Sovio, U; Brocklehurst, P; Heazell, AEP; Thornton, JG; Robson, SC; Papageorghiou, A; Smith, GC (2020) Universal third-trimester ultrasonic screening using fetal macrosomia in the prediction of adverse perinatal outcome: A systematic review and meta-analysis of diagnostic test accuracy. PLoS Med, 17 (10). e1003190. ISSN 1549-1676 https://doi.org/10.1371/journal.pmed.1003190
SGUL Authors: Papageorghiou, Aris

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview
[img] Microsoft Word (.doc) (S1 PRISMA Checklist) Published Version
Available under License Creative Commons Attribution.

Download (67kB)
[img] Microsoft Word (.docx) (S1 Text) Published Version
Available under License Creative Commons Attribution.

Download (13kB)
[img] Microsoft Word (.docx) (S1 Table) Published Version
Available under License Creative Commons Attribution.

Download (26kB)
[img] Microsoft Word (.docx) (S2 Table) Published Version
Available under License Creative Commons Attribution.

Download (52kB)
[img]
Preview
Image (TIFF) (S1 Fig) Published Version
Available under License Creative Commons Attribution.

Download (205kB) | Preview
[img]
Preview
Image (TIFF) (S2 Fig) Published Version
Available under License Creative Commons Attribution.

Download (74kB) | Preview

Abstract

BACKGROUND: The effectiveness of screening for macrosomia is not well established. One of the critical elements of an effective screening program is the diagnostic accuracy of a test at predicting the condition. The objective of this study is to investigate the diagnostic effectiveness of universal ultrasonic fetal biometry in predicting the delivery of a macrosomic infant, shoulder dystocia, and associated neonatal morbidity in low- and mixed-risk populations. METHODS AND FINDINGS: We conducted a predefined literature search in Medline, Excerpta Medica database (EMBASE), the Cochrane library and ClinicalTrials.gov from inception to May 2020. No language restrictions were applied. We included studies where the ultrasound was performed as part of universal screening and those that included low- and mixed-risk pregnancies and excluded studies confined to high risk pregnancies. We used the estimated fetal weight (EFW) (multiple formulas and thresholds) and the abdominal circumference (AC) to define suspected large for gestational age (LGA). Adverse perinatal outcomes included macrosomia (multiple thresholds), shoulder dystocia, and other markers of neonatal morbidity. The risk of bias was assessed using the Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) tool. Meta-analysis was carried out using the hierarchical summary receiver operating characteristic (ROC) and the bivariate logit-normal (Reitsma) models. We identified 41 studies that met our inclusion criteria involving 112,034 patients in total. These included 11 prospective cohort studies (N = 9986), one randomized controlled trial (RCT) (N = 367), and 29 retrospective cohort studies (N = 101,681). The quality of the studies was variable, and only three studies blinded the ultrasound findings to the clinicians. Both EFW >4,000 g (or 90th centile for the gestational age) and AC >36 cm (or 90th centile) had >50% sensitivity for predicting macrosomia (birthweight above 4,000 g or 90th centile) at birth with positive likelihood ratios (LRs) of 8.74 (95% confidence interval [CI] 6.84-11.17) and 7.56 (95% CI 5.85-9.77), respectively. There was significant heterogeneity at predicting macrosomia, which could reflect the different study designs, the characteristics of the included populations, and differences in the formulas used. An EFW >4,000 g (or 90th centile) had 22% sensitivity at predicting shoulder dystocia with a positive likelihood ratio of 2.12 (95% CI 1.34-3.35). There was insufficient data to analyze other markers of neonatal morbidity. CONCLUSIONS: In this study, we found that suspected LGA is strongly predictive of the risk of delivering a large infant in low- and mixed-risk populations. However, it is only weakly (albeit statistically significantly) predictive of the risk of shoulder dystocia. There was insufficient data to analyze other markers of neonatal morbidity.

Item Type: Article
Additional Information: Copyright: © 2020 Moraitis et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Keywords: Birth Weight, Diagnostic Tests, Routine, Female, Fetal Macrosomia, Fetal Weight, Gestational Age, Humans, Mass Screening, Noninvasive Prenatal Testing, Parturition, Pregnancy, Pregnancy Complications, Pregnancy Trimester, Third, Prospective Studies, Retrospective Studies, Ultrasonics, Ultrasonography, Ultrasonography, Prenatal, Humans, Pregnancy Complications, Fetal Macrosomia, Birth Weight, Fetal Weight, Ultrasonography, Ultrasonography, Prenatal, Diagnostic Tests, Routine, Mass Screening, Retrospective Studies, Prospective Studies, Gestational Age, Pregnancy, Parturition, Pregnancy Trimester, Third, Ultrasonics, Female, Noninvasive Prenatal Testing, 11 Medical and Health Sciences, General & Internal Medicine
SGUL Research Institute / Research Centre: Academic Structure > Institute of Medical & Biomedical Education (IMBE)
Academic Structure > Institute of Medical & Biomedical Education (IMBE) > Centre for Clinical Education (INMECE )
Journal or Publication Title: PLoS Med
ISSN: 1549-1676
Language: eng
Dates:
DateEvent
13 October 2020Published
9 September 2020Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
MR/P01271X/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
15/105/01National Institute for Health Researchhttp://dx.doi.org/10.13039/501100000272
PubMed ID: 33048935
Web of Science ID: WOS:000581721000003
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/114779
Publisher's version: https://doi.org/10.1371/journal.pmed.1003190

Actions (login required)

Edit Item Edit Item